SURROZEN INC (SRZN:NASDAQ)
$24.1 -5.59 (-18.8279%)
Analysed SURROZEN INC (SRZN:NASDAQ) News Sources
Surrozen to Present at Upcoming Healthcare Investor Conferences
02-09-2026
yahoo.com
Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update
06-05-2026
yahoo.com
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28-04-2026
yahoo.com
Surrozen to Present at Upcoming Healthcare Investor Conference
12-05-2026
yahoo.com
We're Not Very Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Rate
17-05-2026
yahoo.com
Surrozen Highlights Wnt Retina Pipeline, SZN-8141 IND Timeline at H.C. Wainwright
22-07-2026
marketbeat.com
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
06-08-2026
yahoo.com
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
08-09-2026
yahoo.com
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
02-10-2026
yahoo.com
Surrozen secures FDA clearance for SZN-8141 clinical trial
05-10-2026
clinicaltrialsarena.com
What is the current price of SURROZEN INC (SRZN:NASDAQ)?
The current price of SURROZEN INC (SRZN:NASDAQ) is $24.1.
SURROZEN INC (SRZN:NASDAQ) absolute price change since previous trading day?
The absolute price change of SURROZEN INC (SRZN:NASDAQ) since the previous trading day is $-5.59.
SURROZEN INC (SRZN:NASDAQ) percentage price change since previous trading day?
The percentage price change of SURROZEN INC (SRZN:NASDAQ) since the previous trading day is -18.8279%.
What is the most recent average sentiment score for SURROZEN INC (SRZN:NASDAQ)?
The most recent average sentiment score for SURROZEN INC (SRZN:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for SURROZEN INC (SRZN:NASDAQ)?
The most recent sentiment for SURROZEN INC (SRZN:NASDAQ) is .
SEC-8K** Filing Available For SURROZEN INC (SRZN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.